ISSN: 2173-5786

Actas Urológicas Españolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1974 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology.
Actas Urológicas Españolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided. It has high visibility and accessibility and is found in the most important data bases, Medline/Pubmed, Emabase, JCR, Ïndice Médico Español, Índice bibliográfico Español en Ciencias de la Salud (IBECS), Cuiden, Dialnet, Hinari, Scopus, Google Scholar.

See more Open Access Option

Indexed in:

Science Citation Index Expanded, Journal of Citation Reports, Index Medicus/MEDLINE, Scopus, EMBASE/Excerpta Medica, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

1.9

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.332

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.557

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original article

Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide

El índice nutricional pronóstico como factor pronóstico independiente para la respuesta al tratamiento, la supervivencia y la elección del fármaco en el cáncer de próstata metastásico resistente a la castración tratado con acetato de abiraterona o enzalutamida

A. Küçükarda

Corresponding author

ahmetkucukarda22@gmail.com

Corresponding author.

, A. Gökyer, İ. Gökmen, E. Özcan, M.B. Hacıoğlu, B. Erdoğan, S. Uzunoğlu, İ. Çiçin

Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey

Read

Times
was read the article

Total PDF

Total HTML

Share statistics

Article information

ISSN: 21735786
Original language: English

DOI:10.1016/j.acuroe.2021.12.005

The statistics are updated each day

Year/Month	Html	Pdf	Total

2023 March	3	1	4

Follow this link to access the full text of the article

Publish in

Actas Urológicas Españolas

Actas Urológicas Españolas (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Free access articles

Recommendations on the treatment of metastatic...

Actas Urol Esp. 2024;48:623-31

Changes in benign prostatic hyperplasia management in...

Actas Urol Esp. 2024;48:461-9

Oral care pathways after oral mucosal graft harvesting:...

10.1016/j.acuroe.2024.11.002

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter